These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3784006)
1. [Actual conditions and countermeasures for refractory states in platelet transfusion]. Sezaki T; Hoshijima T; Izumi K Rinsho Ketsueki; 1986 Jul; 27(7):1261-4. PubMed ID: 3784006 [No Abstract] [Full Text] [Related]
2. [Optimal donor selection and the effectiveness of platelet transfusion in cases refractory to platelet transfusion]. Iwanaga T; Tsubaki K; Horiuchi A; Fujikawa Y; Kanemitsu Y Rinsho Ketsueki; 1986 Jul; 27(7):1274-7. PubMed ID: 3784009 [No Abstract] [Full Text] [Related]
3. [Blood platelet transfusion in a refractory state--HLA-matched transfusion and high-dose intravenous immunoglobulin]. Fujii H; Maekawa T; Saji H; Maruya E Rinsho Ketsueki; 1986 Jul; 27(7):1268-73. PubMed ID: 3784008 [No Abstract] [Full Text] [Related]
4. [Platelet and granulocyte transfusion in hematology]. Ouellet P Union Med Can; 1983 May; 112(5):457-60. PubMed ID: 6879858 [No Abstract] [Full Text] [Related]
6. [Transfusion therapy in splenectomy in blood diseases]. Vorob'ev AI; Idel'son LI; Butrov AV; Gorodetskiĭ VM; Abashkin IuA Vestn Khir Im I I Grek; 1982 Oct; 129(10):111-7. PubMed ID: 7179654 [No Abstract] [Full Text] [Related]
7. [Blood donation in a hospital for transfusion in hematological diseases]. Ikeda Y Rinsho Byori; 1991 Mar; Suppl 88():243-7. PubMed ID: 1856975 [No Abstract] [Full Text] [Related]
8. [Future development of platelet transfusion]. Tsubaki K Rinsho Ketsueki; 1998 Feb; 39(2):78-80. PubMed ID: 9545802 [No Abstract] [Full Text] [Related]
9. [Indications for transfusion]. Hollán Z Orv Hetil; 1988 Feb; 129(6):271-6, 279. PubMed ID: 3347478 [No Abstract] [Full Text] [Related]
10. The blood components--advancement in haemotherapy. Nathan IV; Han P J Singapore Paediatr Soc; 1986; 28(3-4):216-26. PubMed ID: 3599928 [No Abstract] [Full Text] [Related]
11. [Need for thrombocytes among hematologic patients. Medical and economic aspects]. Richter J Lakartidningen; 1993 Apr; 90(14):1390-3. PubMed ID: 8479264 [No Abstract] [Full Text] [Related]
12. [Occurrence of refractory states in platelet transfusion in leukemia and its countermeasures]. Baba M; Ito T Rinsho Ketsueki; 1986 Jul; 27(7):1265-7. PubMed ID: 3784007 [No Abstract] [Full Text] [Related]
17. [Progress in treatment with blood and blood preparations with regard to achievements in blood preservation]. Nowicki P Acta Haematol Pol; 1984; 15(3-4):213-21. PubMed ID: 6399433 [No Abstract] [Full Text] [Related]
18. [Platelet transfusion for patients with haematological diseases--indications and transfusion triggers]. Ueda Y Rinsho Ketsueki; 2010 Oct; 51(10):1523-30. PubMed ID: 20962486 [No Abstract] [Full Text] [Related]
19. [Guide for transfusion of red blood cells, platelets and labile plasma products. Joint directive of the Spanish society of blood transfusion]. Algora Weber M; Fernández Montoya A; Gómez Villagrán JL; Martín Vega C; Prats Arrojo I; Puig Alcaraz N; Pujol Bosch M; Vesga Carasa MA Med Clin (Barc); 1999 Oct; 113(12):471-4. PubMed ID: 10570517 [No Abstract] [Full Text] [Related]
20. [Special features of blood transfusions to hematologic patients]. Oksanen K Duodecim; 1998; 114(12):1233-9. PubMed ID: 11524769 [No Abstract] [Full Text] [Related] [Next] [New Search]